{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Oncotelic Therapeutics Inc. (OTLC) Brings AI and Robotics Together in New Platform

July 15, 2026Oncotelic Therapeutics (OTCQB: OTLC) was featured in a recent article that discussed the company’s launch of an AI-powered manufacturing services platform designed to help emerging biotechnology companies overcome one of the industry’s biggest challenges: accessing full GMP infrastructure. “The platform combines Oncotelic’s proprietary PDAOAI(TM) architecture with digital manufacturing technologies and intelligent robotics developed in collaboration with TechForce Robotics, the company’s strategic robotics and automation partner.


BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process

July 15, 2026Regentis Biomaterials (NYSE American: RGNT) announced it has received approval from the European Notified Body to manufacture GelrinC(R) using its next-generation solvent-free manufacturing process, a milestone that supports the product’s planned commercial launch in Europe. The company said the new process increases production yield by approximately 400%, producing five times more product from the same manufacturing volume while improving manufacturing efficiency, scalability and occupational and environmental safety.


AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Semiconductor Equipment Makers Benefit from AI Infrastructure Expansion

July 15, 2026Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, is featured in a new AINewsWire editorial examining how the AI infrastructure buildout is driving demand beyond chips to the precision automation, robotics and semiconductor production equipment needed to manufacture them. The editorial highlights the company’s evaluation of a dual-region manufacturing expansion of up to 100,000 square feet across Taiwan and the U.


Backlash Prompts Meta to Take Down its AI Image Generation Feature

July 15, 2026Meta has removed its newly launched Muse Image tool after facing widespread backlash over privacy concerns and automatic enrollment of public account users. The feature enrolled all public-facing profile users by default unless they manually disabled it in settings.


BioMedNewsBreaks — Kairos Pharma Ltd. (NYSE American: KAPA) Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer

July 15, 2026Kairos Pharma (NYSE American: KAPA) announced favorable interim safety results from its ongoing Phase 1 trial evaluating ENV-105 (carotuximab) in combination with osimertinib (Tagrisso(R)) for patients with advanced EGFR-mutated non-small cell lung cancer (“NSCLC”) who have developed resistance to osimertinib. The company reported no Grade 3 or higher treatment-related adverse events among 13 patients treated with ENV-105 to date, supporting continued advancement of the program toward an early efficacy readout.


NetworkNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Announces Aug. 1 Launch of XcellaraHeart Cardiovascular Wellness Supplement

July 15, 2026BioAdaptives (OTC: BDPT) announced the upcoming commercial launch of XcellaraHeart(TM), a cardiovascular wellness supplement that combines the company’s Xcellara(TM) stem/progenitor cell mobilization formula with Tanshinone IIA, a bioactive compound derived from Danshen root. The company said the Xcellara(TM) base is supported by a randomized, double-blind, placebo-controlled clinical trial that demonstrated an average 268.